Uncategorized

Talga Group Ltd (ASX:TLG) has announced that the Swedish Supreme Court has dismissed all requests to appeal the Environmental and Natura 2000 permit for its Nunasvaara South natural graphite mine, part of the Vittangi Anode Project in northern Sweden. Shares are trading 45.68 per cent higher at $0.59. Locksley Resources Limited (ASX:LKY) announced results from […]

INOVIQ (ASX:IIQ) highlighted progress in its diagnostic and therapeutic programs in its quarterly update for the period ending 30 September 2024. The company specialises in the early detection and treatment of cancer and neurodegenerative diseases. Its EXO-NET technology enables the capture and isolation of “exosomes”, which are are tiny extracellular vesicles released by cells that carry molecular

PointsBet Holdings (ASX:PBH), a Melbourne-based sports betting and iGaming company, has reported steady growth in Q1 FY25, driven by a balanced approach of market expansion and cost optimisation. PointsBet operates across Australia, the United States, and Canada, with a focus on digital, in-play sports betting that lets users place real-time bets during live events. The

Corporate Travel Management (ASX:CTD) shared strong progress in a market update released today ahead of the company’s Annual General Meeting.  The report indicates gains in the company’s primary markets and effective cost management strategies. The Brisbane-based company operates across Australia, New Zealand, North America, Asia and Europe, providing tailored travel management solutions for corporate clients.

The Australian Bureau of Statistics (ABS) released a range of economic updates today, highlighting shifts across building approvals, export prices, and retail spending for September 2024. In building approvals, the seasonally adjusted total for dwellings rose by 4.4% to 14,842 units in September. This uptick follows a 3.9% fall in August. Private sector house approvals

In its quarterly report for the period ending 30 September 2024, BluGlass (ASX:BLG) shared details of a partnership with Uviquity, a US-based startup specialising in wide-bandgap semiconductors and integrated photonics. Under a multi-year Joint Development Agreement (JDA) announced on 31 October, BluGlass will receive an initial $1.2m for the first phase of a project to

Mineral Resources (ASX:MIN) has announced a pivotal $1.13bn deal with Hancock Prospecting, selling 100% of its exploration permits in the Perth Basin and forming joint ventures on remaining assets across the Perth and Carnarvon basins. This transaction, including an $804m upfront payment and up to $327m in resource-dependent bonuses, reflects MinRes’s strategy of leveraging high-value

Coles Group (ASX:COL) reported mixed results in its first quarter of FY2025, highlighting growth in some segments while grappling with tightened consumer spending in others. The company posted a 2.9% rise in total group revenue to reach $10.55bn for the 13 weeks ending 29 September 2024. Coles Supermarkets led the growth, with sales climbing 3.5%

JB Hi-Fi (ASX:JBH) has announced Q1 FY25 results, with a 4.9% total sales growth in JB Hi-Fi Australia, 19.6% growth in New Zealand, and 5.3% for The Good Guys, its consumer electronics and home appliances arm.  In FY24, JB Hi-Fi reached $9.6bn in sales, with a net profit after tax of $438.8m and a closing

Mesoblast (ASX:MSB; Nasdaq:MESO) has reported significant milestones in its Q1 FY2025 results, including an anticipated FDA decision on its lead product, Ryoncil (remestemcel-L), for treating steroid-refractory acute graft versus host disease (SR-aGvHD) in children. Filed in July, the company expects an FDA verdict by 7 January 2025. Ryoncil would be the first FDA-approved treatment specifically